Yukikazu Kaino

Suggest Changes
Learn More
UNLABELLED Aims/Introduction:  The therapeutic effectiveness against type 1 diabetes mellitus (DM) of the novel immunomodulator FTY720 (fingolimod), alone and in combination with insulin glargine,(More)
  • 1